IRVINE, Calif., February 12, 2026 – Medtronic plc announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated. The acquisition is valued at up to $585 million with potential undisclosed earn-out payments post-acquisition.
A team from Knobbe Martens advised CathWorks on intellectual property aspects of the deal.
The intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the CathWorks FFRangio® System in the U.S., Europe and Japan, where it is commercially available. Using a combination of artificial intelligence and advanced computational science, the CathWorks FFRangio® System is the only angiography-derived system that delivers FFR values along the entire coronary tree. In addition, it provides intraprocedural optimization tools, including assessment of the physiological impact of lesion treatment and interactive sizing tools to measure lesion dimensions. Together, these capabilities empower physicians with deeper physiological insights to support confident, patient-centered treatment decisions.
More information on the acquisition can be found here.
The Knobbe Martens team that advised CathWorks on the deal included Medical Device practice co-chair Sabing Lee, Michael Christensen, Brian Graham, and Justin Theam.
About Knobbe Martens’ Medical Devices & Procedures Experience
Knobbe Martens is an undisputed leader in medical device IP law, having filed more than 40,000 patent applications in the medical device arts alone, helped hundreds of medical device companies get acquired or go public, and successfully litigated numerous medical device IP cases, several through trial and appeal. Our team of attorneys provides guidance in all stages of development through capital formation, transactional due diligence, patent landscape (market clearance) evaluations, strategic patent prosecution, licensing and other IP agreements, trade secrets, third party patent evaluations, IP audits and, when necessary, IP litigation.
About Knobbe Martens
Knobbe Martens protects the ideas that drive innovation and propel our world forward. As a leading intellectual property and technology law firm, clients worldwide rely on us to safeguard their products, brands, and technologies through strategic counsel and high-impact litigation. With offices across the U.S., our lawyers and technology specialists collaborate to deliver tailored solutions for clients ranging from multinational corporations to start-ups and emerging companies at every stage. Discover more at www.knobbe.com.
Subscribe for News and Updates
